Waltz Comments on Extension of Moratoria on New Home Health Agencies in Six States
January 30, 2018
Bloomberg BNA – Health Law Resource Center
Partner Judith Waltz is quoted in a BNA Health Care Policy Report article, “New Home Health Agencies in Six States? Medicare Still Says No,” about a decision by the Centers for Medicare & Medicaid Services to extend by six months a temporary moratorium on new home health agencies in six states.
Waltz said questions have been raised as to the effectiveness of blocking Medicare or Medicaid enrollment for an entire provider category, citing a ban on the enrollment of new clinical laboratories in California for several years, which industry stakeholders said had had an adverse impact on access to genetic testing for California patients.
“Moratoria also skew the market for existing providers who want to sell their entities as ongoing operations, since prospective providers can only get an enrollment with a continuing entity,” she said. Existing providers can also sell their practice for a premium under a moratorium, she added.
Metrics also are lacking for the moratoria, Waltz said, making it difficult to assess whether the program has been a success. “It’s impossible to tell if the moratoria really work because they are based on prevention and avoidance rather than recovery, so in essence it would require proving a negative to estimate the effectiveness,” she said.
Waltz said questions have been raised as to the effectiveness of blocking Medicare or Medicaid enrollment for an entire provider category, citing a ban on the enrollment of new clinical laboratories in California for several years, which industry stakeholders said had had an adverse impact on access to genetic testing for California patients.
“Moratoria also skew the market for existing providers who want to sell their entities as ongoing operations, since prospective providers can only get an enrollment with a continuing entity,” she said. Existing providers can also sell their practice for a premium under a moratorium, she added.
Metrics also are lacking for the moratoria, Waltz said, making it difficult to assess whether the program has been a success. “It’s impossible to tell if the moratoria really work because they are based on prevention and avoidance rather than recovery, so in essence it would require proving a negative to estimate the effectiveness,” she said.
People
Related News
June 25, 2025
In the News
Jocelyn Lavallo Explores Nuclear's Emerging Role in Project Finance
Foley & Lardner LLP partner Jocelyn Lavallo examined the increasing relevance of advanced nuclear technologies in the evolving clean energy landscape in her Environment+Energy Leader article, "Nuclear’s Emerging Role in Project Finance: A Cross-Technology Perspective."
June 25, 2025
In the News
Kyle Faget Comments on AI, User Fees Ahead of MDUFA Negotiations
Foley & Lardner LLP partner Kyle Faget weighed in on the role of user fees and artificial intelligence as stakeholders prepare for the next Medical Device User Fee Amendments (MDUFA) reauthorization in the Medtech Insight article, "Will Kennedy And Makary Come To Terms On User Fees During Next Round Of MDUFA Negotiations?"
June 25, 2025
In the News
Foley Chairman Daljit Doogal Talks Strategic Growth, Expansion into Three New Markets on Podcast
Foley & Lardner LLP Chairman and CEO Daljit Doogal joined an episode of the On the Merits podcast with Bloomberg Law to tell the story of Foley’s successful strategic expansion into three emerging legal markets within the last four years.